23andMe's Wojcicki on How to Handle Regulatory Challenges

The transcript covers a range of topics including Hillary Clinton's qualifications and support, concerns about immigration policies affecting Silicon Valley, and the challenges faced by 23andMe with regulatory issues. It discusses 23andMe's innovative approach to drug development using genetic data and the importance of transparency, drawing lessons from Theranos. The future vision for 23andMe includes partnerships and advancements in consumer healthcare.

How does the speaker describe the spirit of Silicon Valley?

What does the speaker identify as critical for success in the healthcare industry?

In what ways does the speaker believe 23andMe is different from its competitors?